Bizotic Commercial Revises Warrant Issue to 1.33 Crore Units

Bizotic Commercial Limited has revised the proposed size of its preferential convertible-warrant issue to 1,33,10,400 warrants at ₹110 each, according to a corrigendum issued on 30 October 2026. The revision recasts Item No. 2 of the company's 23 October EGM notice and follows its plan to increase authorised share capital to ₹71.50 crore.

What has Bizotic Commercial changed in its warrant proposal?

Bizotic Commercial has revised the proposed preferential issue to 1,33,10,400 warrants convertible into equity shares, with each warrant priced at ₹110. The company disclosed the revision through a corrigendum to the EGM notice on 30 October 2026, specifically recasting Item No. 2 dealing with the warrant issuance.

The issue had previously been described as an allotment of up to 1,36,08,000 convertible warrants to promoter and non-promoter investors. The corrigendum therefore changes the number of warrants proposed under the preferential issue. The available information continues to identify the proposed recipients broadly as persons or entities in the promoter, promoter group and public categories.

Each warrant carries a face value of ₹10 and a premium of ₹100, based on the board's price determination disclosed on 30 September. The relevant date for the preferential issue under the SEBI (Issue of Capital and Disclosure Requirements) Regulations, 2018 was set as 23 September 2026.

When did Bizotic Commercial place the proposals before shareholders?

Bizotic Commercial placed the capital and warrant-related proposals before shareholders at its fifth Extra-Ordinary General Meeting on 23 October 2026. The meeting was held through video conferencing and other audio-visual means, began at 12:00 p.m. and concluded at 12:07 p.m.

The first agenda item sought an increase in authorised share capital and a corresponding alteration to the capital clause of the Memorandum of Association. It was moved as an ordinary resolution. The second item concerned the preferential issuance of warrants convertible into equity shares and was moved as a special resolution.

The company had announced the EGM on 30 September after its board finalised the issue price and capital structure. The board's decisions followed the initial approval of the preferential-issue agenda at a meeting held on 10 September 2026. Bizotic Commercial subsequently submitted voting results and the scrutiniser's report relating to the 23 October EGM.

Why is the authorised capital increase part of the transaction?

The authorised capital increase is intended to create headroom within Bizotic Commercial's capital structure for the proposed equity-linked issuance. The board approved an increase in authorised share capital to ₹71.50 crore, which would accommodate 7.15 crore equity shares of ₹10 each, compared with the earlier authorised level of 5.786 crore shares.

Authorised share capital is the maximum share capital a company can issue under its constitutional documents. Any increase requires an alteration to the capital clause in the Memorandum of Association, which is why the company placed this as a separate item before shareholders.

The revised warrant count and the capital increase are related but distinct actions. The capital increase changes the authorised limit, while the preferential issue sets out the proposed allocation of instruments that can convert into equity shares under the disclosed terms.

What does the preferential issue mean for investors and operations?

The preferential issue could expand Bizotic Commercial's equity share base if the warrants are allotted and subsequently converted into shares. The corrigendum identifies a revised number of warrants but does not provide, in the supplied disclosures, a revised post-conversion shareholding structure or a stated use of proceeds.

For existing shareholders, a potential increase in outstanding equity shares is relevant because it can affect relative ownership when warrants convert. The issue price of ₹110 is a disclosed transaction term, while the final effect on the company's capital base depends on allotment and conversion under the applicable terms.

Bizotic Commercial operates in trading of fabric material and garments. Its business description also covers the manufacturing, designing and marketing of ready-made menswear under the Urban United brand, alongside wholesale and retail trading in men's ready-made garments and fabrics.

The company reported net profit of ₹428.61 lakh for the year ended 31 March 2025 in its ninth annual report. No revenue figure or financial purpose for the revised warrant issue is stated in the supplied material, so the financial deployment of any funds cannot be assessed from these disclosures.

How does the corrigendum fit Bizotic Commercial's recent corporate actions?

The corrigendum follows a sequence of capital-related actions initiated in September 2026. Bizotic Commercial first approved the preferential-issue agenda on 10 September, then set the price at ₹110 and approved the authorised-capital increase at its 30 September board meeting before convening the 23 October EGM.

The company has used shareholder meetings for capital and governance matters in the recent past. Its March 2026 EGM addressed the appointment of statutory auditors following an auditor resignation and noted the resignation of its chief financial officer and executive director. Earlier disclosures also referred to preferential issues and amendments to meeting notices.

For the market, the key disclosed development is the corrected size of the potential equity-linked issue. Investors will need to distinguish between the resolution process, the proposed allotment, and eventual conversion of warrants, as each stage has a different effect on the company's capital structure.

Conclusion

Bizotic Commercial's 30 October corrigendum reduces the disclosed proposed warrant count from the earlier figure of up to 1,36,08,000 to 1,33,10,400, while retaining the ₹110 price. The change comes after the company placed both the authorised-capital increase and preferential warrant issue before shareholders at its 23 October EGM.

The next point to watch is the company's formal disclosure on implementation of the recast Item No. 2, including any allotment details, recipient-wise information and conversion terms. The supplied disclosures do not state a use of proceeds or a revised post-conversion shareholding pattern.